Nateglinide: a new rapid-acting insulinotropic agent

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.6, 2001-06, pp. : 1027-1031

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetics of Nateglinide: A Rapidly-Absorbed, Short-Acting Insulinotropic Agent

By McLeod J.F.

Clinical Pharmacokinetics, Vol. 43, Iss. 2, 2004-01 ,pp. : 97-120

Adis International

Access to resources Recommend Favorite

Effect of insulinotropic agent nateglinide on Kv and Ca 2+ channels in pancreatic -cell

By Hu S. Wang S.

European Journal of Pharmacology, Vol. 427, Iss. 2, 2001-09 ,pp. : 97-104

Elsevier

Access to resources Recommend Favorite

Mitiglinide: a rapid- and short-acting non-sulfonylurea insulinotropic agent for the treatment of type 2 diabetic patients

By Malaisse Willy J

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2691-2698

Informa Healthcare

Access to resources Recommend Favorite

Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes

By Garg Satish K Ellis Samuel L Ulrich Heather

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 4, 2005-04 ,pp. : 643-651

Informa Healthcare

Access to resources Recommend Favorite

Rapid-Acting Antidepressants

Current Pharmaceutical Design, Vol. 24, Iss. 22, 2018-06 ,pp. : 2556-2563

Bentham Science Publishers

Access to resources Recommend Favorite